EPI2ME 25.05-01 Release![Stephen Rudd]()
With our London Calling 2025 EPI2ME release we are delighted to introduce a collection of…
May 21, 2025
3 min
#workflows 65
Phasing of small insertions and deletions
One of the major advantages of long-read sequencing is its ability to resolve phasing — identifying…
May 14, 2025
1 min
EPI2ME 25.04-01 Release![Stephen Rudd]()
Dear Nanopore Community, we are pleased to introduce a maintenance update for our EPI2ME workflows…
April 16, 2025
2 min
EPI2ME 24.09-01 Release![Stephen Rudd]()
Dear Nanopore Community, In this late summer release, we are pleased to introduce a collection of…
September 21, 2024
1 min
EPI2ME 24.08-01 Release![Stephen Rudd]()
Dear Nanopore Community, In this late summer release, we are pleased to introduce a collection of…
August 15, 2024
1 min
Unexpected results, so now what?
You just finished the lab work for the experiment that will save the future of humankind.
A huge…
July 02, 2024
3 min
Page 1 of 11
Related Links
© 2020 - 2025 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.